The oncological role of surgical resection in non-contrast-enhancing glioblastomas with low-grade appearance
Advancing Chimeric Antigen Receptor (CAR) technology for Glioblastoma treatment: Preclinical insights and therapeutic potential
Determinants of long-term survival in patients with IDH-mutant gliomas